507 related articles for article (PubMed ID: 12835706)
1. Immunopathogenesis and immunotherapy in AIDS virus infections.
Letvin NL; Walker BD
Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T-cell recognition of HIV proteins and peptides.
Nixon DF; McMichael AJ
AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
[No Abstract] [Full Text] [Related]
3. Progression of HIV to AIDS: a protective role for HLA-B27?
den Uyl D; van der Horst-Bruinsma IE; van Agtmael M
AIDS Rev; 2004; 6(2):89-96. PubMed ID: 15332431
[TBL] [Abstract][Full Text] [Related]
4. The role of human leukocyte antigen E and G in HIV infection.
Tripathi P; Agrawal S
AIDS; 2007 Jul; 21(11):1395-404. PubMed ID: 17589185
[No Abstract] [Full Text] [Related]
5. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
Brander C; Walker BD
Curr Opin Immunol; 1999 Aug; 11(4):451-9. PubMed ID: 10448136
[TBL] [Abstract][Full Text] [Related]
6. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.
Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P
Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642
[TBL] [Abstract][Full Text] [Related]
8. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
9. Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.
Sereti I; Lane HC
Clin Infect Dis; 2001 Jun; 32(12):1738-55. PubMed ID: 11360217
[TBL] [Abstract][Full Text] [Related]
10. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV adaptive immunity: determinants for viral persistence.
Yamamoto H; Matano T
Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
[TBL] [Abstract][Full Text] [Related]
12. The value of preserving HIV-specific immune responses.
Kaufmann DE; Rosenberg ES
J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
Betts MR; Gray CM; Cox JH; Ferrari G
Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
[TBL] [Abstract][Full Text] [Related]
14. Living in oblivion: HIV immune evasion.
Piguet V; Trono D
Semin Immunol; 2001 Feb; 13(1):51-7. PubMed ID: 11289799
[TBL] [Abstract][Full Text] [Related]
15. HIV and human leukocyte antigen association--the Indian scenario.
Shankarkumar U
J HIV Ther; 2004 Sep; 9(3):60-4. PubMed ID: 15534563
[TBL] [Abstract][Full Text] [Related]
16. HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting.
Paris R; Bejrachandra S; Karnasuta C; Chandanayingyong D; Kunachiwa W; Leetrakool N; Prakalapakorn S; Thongcharoen P; Nittayaphan S; Pitisuttithum P; Suriyanon V; Gurunathan S; McNeil JG; Brown AE; Birx DL; de Souza M
Tissue Antigens; 2004 Sep; 64(3):251-6. PubMed ID: 15304005
[TBL] [Abstract][Full Text] [Related]
17. Current concepts in clinical therapeutics: immunologic treatment of human immunodeficiency virus infections.
Purdy BD; Plaisance KI
Clin Pharm; 1987 Nov; 6(11):851-65. PubMed ID: 2445517
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.
Cohen DE; Walker BD
Clin Infect Dis; 2001 Jun; 32(12):1756-68. PubMed ID: 11360218
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis of human immunodeficiency virus.
Ahsan N; Langhoff E
Semin Nephrol; 1998 Jul; 18(4):422-35. PubMed ID: 9692354
[TBL] [Abstract][Full Text] [Related]
20. [Cytokines and HIV infection].
Emilie D
Pathol Biol (Paris); 1993 May; 41(5):449-52. PubMed ID: 8414676
[No Abstract] [Full Text] [Related]
[Next] [New Search]
